RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Cancer
Interventions: BIOLOGICAL: monoclonal antibody RAV12
Sponsor: MacroGenics